Press release from Companies: Första patienten i behandling i RhoVacs kliniska fas IIb-studie i Sverige

Press release from Companies: RhoVac appoints Professor Georg Holländer to its Scientific Advisory Board

Press release from Companies: RhoVac rekryterar professor Georg Holländer till sitt vetenskapliga råd

Reports: RhoVac AB presenterar delårsrapport Q2 2020

Press release from Companies: First patient in treatment in RhoVac's clinical phase IIb study in the USA

Press release from Companies: Första patienten i behandling i RhoVacs kliniska fas IIb-studie i USA

More from the company: A RhoVac article is published in the June edition of MedNous, a publication of Evernow Publishing Ltd

Press release from Companies: RhoVac omnämns i en artikel publicerad i juniupplagan av MedNous, en publikation av Evernow Publishing Ltd

More from the company: RhoVac marknadsförs i internationell press

More from the company: RhoVac marketed in international press

Press release from Companies: RhoVac receives approval in Sweden to start clinical phase IIb trial

Press release from Companies: RhoVac erhåller godkännande i Sverige för start av klinisk fas IIb-studie